TTK Healthcare Limited (TTKHLTCARE) AI Stock Analysis

TTK Healthcare Limited

(NSE:TTKHLTCARE)

Select Model

Rating:59Neutral

Price Target:INR 946.00▲(3.47% Upside)

Action:downgraded

Date:10/31/26

Financial performance leads with balance sheet strength and revenue growth, partially offset by cash flow weakness; bearish technical indicators further constrain the score while fair valuation offers modest support.

Positive Factors

Conservative balance sheetVery low leverage gives TTK Healthcare substantial financial flexibility and reduces solvency pressure during operating volatility. A growing equity base and asset position can support investment in products, distribution, and healthcare opportunities without relying heavily on external borrowing.

Negative Factors

Sustained cash burnPersistent negative operating and free cash flow means reported earnings are not translating into cash generation. This reduces financial flexibility despite low debt and may constrain the company’s ability to fund growth, absorb working-capital demands, or return capital without relying on its balance-sheet resources.

TTK Healthcare Limited (TTKHLTCARE) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 12.79B
Dividend Yield: 1.10%
Average Volume (3M): 2,093
Price to Earnings (P/E): 17.3
Beta (1Y): 0.85
Revenue Growth: 8.34%
EPS Growth: 17.25%
Country: India
Employees: 1,478
Sector: General
Sector Strength: 55
Industry: Drug Manufacturers - General

TTK Healthcare Limited Business Overview & Revenue Model

Company Description

TTK Healthcare Limited is a diversified enterprise operating across multiple sectors in India and globally. Its extensive activities encompass animal welfare, offering veterinary therapeutic solutions and feed supplements. The human pharmaceuticals d...

How the Company Makes Money

TTK Healthcare primarily makes money by selling healthcare products and medical devices under its own brands and through institutional supply. Its revenue model is driven by: (1) Consumer healthcare sales: Revenue from branded consumer/OTC healthcare...

TTK Healthcare Limited Financial Statement Overview

Summary

Strong balance sheet with minimal debt and growing equity supports stability, aided by consistent revenue expansion, but recent negative cash flows and volatility in margins limit the score.

Income Statement

70Positive

Balance Sheet

90Very Positive

Cash Flow

30Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	8.88B	8.57B	8.73B	7.48B	7.25B	5.99B
Gross Profit	3.37B	2.80B	5.04B	4.07B	3.77B	3.09B
EBITDA	883.75M	261.76M	1.06B	999.35M	797.92M	412.65M
Net Income	739.60M	656.80M	816.57M	628.42M	6.40B	415.88M
Balance Sheet
Total Assets	0	13.29B	12.81B	12.01B	11.70B	5.59B
Cash, Cash Equivalents and Short-Term Investments	9.36B	9.75B	8.55B	8.45B	8.47B	2.73B
Total Debt	0	243.78M	242.19M	228.11M	273.29M	222.13M
Total Liabilities	-11.15B	2.14B	2.16B	2.00B	2.17B	2.29B
Stockholders Equity	11.15B	11.15B	10.65B	10.01B	9.53B	3.30B
Cash Flow
Free Cash Flow	-254.40M	-269.50M	-168.16M	-153.27M	-377.75M	385.02M
Operating Cash Flow	-225.48M	-211.48M	-39.76M	-49.43M	-260.76M	449.96M
Investing Cash Flow	397.52M	515.79M	201.03M	284.94M	329.59M	-305.47M
Financing Cash Flow	-135.11M	-175.56M	-180.81M	-219.11M	-124.26M	-51.77M

TTK Healthcare Limited Technical Analysis

Technical Analysis SentimentNegative

Last Price914.25

Price Trends

50DMA1056.40Negative

100DMA1018.44Negative

200DMA957.56Negative

Market Momentum

MACD-20.64Positive

RSI34.99Neutral

STOCH48.71Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TTKHLTCARE, the sentiment is Negative. The current price of 914.25 is below the 20-day moving average (MA) of 1005.42, below the 50-day MA of 1056.40, and below the 200-day MA of 957.56, indicating a bearish trend. The MACD of -20.64 indicates Positive momentum. The RSI at 34.99 is Neutral, neither overbought nor oversold. The STOCH value of 48.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:TTKHLTCARE.

TTK Healthcare Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:TTKHLTCARE against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:ABBOTINDIA	81Outperform	INR 543.84B	33.74	―	2.05%	6.29%	11.18%
IN:CIPLA	79Outperform	INR 1.11T	38.44	―	2.10%	-0.74%	-46.77%
IN:SANOFI	70Outperform	INR 73.80B	20.24	―	3.84%	-5.74%	2.30%
IN:GLAXO	68Neutral	INR 420.73B	39.56	―	2.29%	5.75%	12.41%
IN:TTKHLTCARE	59Neutral	INR 12.80B	17.30	―	1.10%	8.34%	17.25%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

* General Sector Average

Performance Comparison

IN:TTKHLTCARE and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:TTKHLTCARE	TTK Healthcare Limited	905.70	-265.76	-22.69%
IN:ABBOTINDIA	Abbott India Limited	25593.30	-2826.16	-9.94%
IN:CIPLA	Cipla Ltd	1380.00	-117.54	-7.85%
IN:GLAXO	GlaxoSmithKline Pharmaceuticals Limited	2483.55	-135.33	-5.17%
IN:SANOFI	Sanofi India Limited	3204.40	-1441.42	-31.03%
IN:SANOFICONR	Sanofi Consumer Healthcare India Limited	3435.05	-1279.73	-27.14%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 31, 2026

TTK Healthcare Limited AI Stock Analysis